Skip to main content
Fig. 4 | Stem Cell Research & Therapy

Fig. 4

From: IGF-1C domain–modified hydrogel enhanced the efficacy of stem cells in the treatment of AMI

Fig. 4

CS-IGF-1C hydrogel increased hP-MSC survival in vivo. a Representative BLI of mice transplanted with hP-MSCs, hP-MSCs + CS hydrogel, or hP-MSCs + CS-IGF-1C hydrogel. b Quantitative analysis of BLI signals showed that cell survival was improved by CS-IGF-1C hydrogel. Data are expressed as mean ± SEM. *P < 0.05 versus hP-MSCs; #P < 0.05 versus hP-MSCs + CS. c Representative photomicrographs displayed the engraftment of GFP+ hP-MSCs delivered with CS-IGF-1C hydrogel, CS hydrogel, or PBS on day 7. Scale bar, 100 μm. d Quantification analysis of GFP+ hP-MSCs delivered with CS-IGF-1C hydrogel, CS hydrogel, or PBS. **P < 0.01 versus PMSCs

Back to article page